Translational Research and Biomarker Development - CD BioSciences

service-banner

Translational Research and Biomarker Development

Translational Research and Biomarker Development

Biomarker Research

Accelerate your drug discovery and clinical development pipelines with CD BioSciences’ comprehensive Translational Research and Biomarker Development solutions. Bridging the gap between novel benchtop discoveries and clinical applications, we offer end-to-end support for precision biomarker identification, functional validation, and clinical translation.

Leveraging our state-of-the-art laboratory platforms, extensive tissue biobank resources, and deep pathology expertise, we empower biopharmaceutical partners to decipher mechanisms of action (MoA), evaluate therapeutic efficacy, and establish robust patient stratification strategies—ultimately de-risking clinical trials and accelerating time-to-market.

Core Services

End-to-End Biomarker Solutions
01

Biomarker Screening, Identification & Validation

Systematic multi-omics discovery and analytical assay validation for actionable biomarker profiles.

Multi-omics profiling across genomic, transcriptomic, and proteomic layers.
Rigorous assay validation ensuring sensitivity, specificity, and reproducibility.
02

Tissue-Based Biomarker Research

Morphological and spatial profiling across diverse human tissue specimens.

In-depth histopathology utilizing FFPE, fresh-frozen tissue, and tissue microarrays (TMAs).
High-plex IHC, multiplex IF, and ISH for precise spatial cellular phenotyping.
03

Clinical Relevance & Correlation Analysis

Connecting molecular insights with clinical outcomes and therapeutic response.

Correlating expression with clinical endpoints, disease stage, and overall survival.
Advanced bioinformatic workflows to map target interaction networks.
04

Mechanism of Action (MoA) & Efficacy

Deciphering drug engagement and pharmacodynamic response in tissue environments.

Evaluating target engagement and downstream resistance pathways.
Quantitative PK/PD biomarker alignment in tumor microenvironments.

Ready to Unlock the Full Potential of Your Biomarker Pipeline?

Partner with CD BioSciences to streamline your translational research, validate critical biomarkers, and optimize patient stratification for your next-generation therapeutics.